Diagnosis And Treatment

The diagnosis of rabies is frequently made postmortem. This occurs because of the rarity of the disease, the increasing numbers of persons without an obvious exposure, and clinical confusion with other disorders. Important clues to diagnosis include a history of an animal bite and the development of the pathognomonic signs of hydrophobia and aerophobia. Tetanus should not be confused with rabies, because in tetanus the mental status is usually normal and the cerebrospinal fluid is normal. Other diseases that may be confused with rabies include poliomyelitis, Guillain-Barre syndrome, transverse myelitis, postvaccinial encephalomyelitis, intracranial mass lesions, cerebrovascular accidents, and poisoning with atropine-like compounds.

During the incubation period of rabies, no diagnostic test is available for either animals or persons that will indicate infection. Routine laboratory tests are of limited value for the diagnosis of rabies. Specific tests are required to diagnose rabies. Because no single test is uniformly informative, a battery of tests is commonly recommended. Early in the course of illness, the most reliable diagnostic test is a nuchal skin biopsy with immunofluorescent rabies antibody staining. Once clinical symptoms develop, a brain biopsy is universally positive when properly stained, but the invasive nature of this test precludes routine use. RFFIT may be performed on serum to detect rabies antibodies. However, while serum antibody may be present as early as day 5 of clinical illness, it may be absent after 10 to 14 days or more. Rabies virus has been isolated antemortem from human saliva, brain tissue, cerebrospinal fluid, urine, and tracheal secretions. Recently, nested PCR of RNA extracted from saliva has been shown to be a sensitive test. However, further study is required before this test can replace virus isolation as a standard antemortem diagnostic test.

No specific therapy exists to treat rabies. Treatment is directed at the clinical complications of the disease. 9 CHAPTER REFERENCES

1. Rupprecht CE, Smith JE, Fekadu M, et al: The ascension of wildlife rabies: A cause for health concern or intervention? Emerg Infect Dis 1:107, 1995.

2. Krebs JW, Long-Marin SC, Childs JE: Causes, costs, and estimates of rabies postexposure prophylaxis treatments in the United States. J Public Health Manage Pract 4:56, 1998.

3. Fishbein DB: Rabies. Infect Dis Clin North Am 5:53, 1991.

4. Frenia ML, Lafin SM, Barone JA: Features and treatment of rabies. Clin Pharm 11:37, 1992.

5. Fishbein DB, Robinson LE: Current concepts: Rabies. N Engl J Med 329:1632, 1993.

6. Smith JS: New aspects of rabies with emphasis on epidemiology, diagnosis, and prevention of the disease in the United States. Clin Microbiol Rev 9:166, 1996.

7. Haburchak DR: Rabies reconsidered: Is the increasing zoonotic reservoir a new public threat? Infect Med 14:943, 1997.

8. Baer GM, Bellini WJ, Fishbein DB: Rhabdoviruses, in Fields BN, Knipe DM (eds): Virology. New York, Raven Press, 1990, p 883.

9. Fishbein DB, Bernard KW: Rabies virus, in Mandell GL, Bennett JE, Dolin R (eds): Principles and Practices of Infectious Diseases, 4th ed. New York, Churchill Livingstone, 1995, p 1527.

10. Dietzschold B, Rupprecht CE, Fu ZF, et al: Rhabdoviruses, in Fields BN, Knipe DM, Howley PM (eds): Virology, 3rd ed. Philadelphia, Lippincott-Raven, 1996, p 1137.

11. Rupprecht CE, Hanlon CA: Rabies, in Evans AS, Kaslow RA (eds): Viral Infections of Humans, 4th ed. New York, Plenum Medical Book Company, 1997, p 665.

12. Bleck TP, Rupprecht CE: Rhabdoviruses, in Richman DD, Whitley RJ, Hayden FG (eds): Clinical Virology. New York, Churchill Livingstone, 1997, p 879.

13. Hanlon CA, Rupprecht CE: The reemergence of rabies, in Scheld WM, Armstrong D, Hughes JM (eds): Emerging Infections I. Washington, DC, ASM Press, 1998, p 59.

15. Krebs JW, Smith JS, Rupprecht CE, et al: Rabies surveillance in the United States during 1996. JAMA 2111:1525, 1997.

16. Held JR, Tierkel ES, Steele JH: Rabies in man and animals in the United States, 1946-1965. Pub Health Rep 82:1009, 1967.

17. Anderson LJ, Nicholson KG, Tauxe RV, et al: Human rabies in the United States, 1960 to 1979: Epidemiology, diagnosis, and prevention. Ann Intern Med 100:728, 1984.

18. Noah DL, Drenzek CL, Smith JS, et al: Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med 128:922, 1998.

19. Centers for Disease Control and Prevention: Human rabies prevention—United States, 1999. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 48(RR-1):1, 1999.

20. Weber DJ, Hansen AR: Infections resulting from animal bites. Infect Dis Clin North Am 5:663, 1991.

21. Garner JS: Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 17:53, 1996.

22. Centers for Disease Control and Prevention: Human rabies—Texas and New Jersey, 1997. MMWR 47:1, 1998.

23. Centers for Disease Control and Prevention: Compendium of animal rabies control, MMWR 48(RR-3):1, 1999.

24. Anonymous. A new rabies vaccine. Med Lett Drugs Ther 40:64, 1998.

25. Wilde H, Bhanganada K, Chutivongse S, et al: Is injection of contaminated animal bite wounds with rabies immune globulin a safe practice? Trans R Soc Trop Med Hyg 86:86, 1992.

26. Lang J, Plotkin SA: Rabies risk and immunoprophylaxis in children. Adv Pediatr Infect Dis 13:219, 1998.

27. Fishbein DB, Bernard KW, Miller KD, et al: The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine. Am J Trop Med Hyg 35:663, 1986.

28. Centers for Disease Control and Prevention: Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of vaccines and immune globulins in persons with altered immunocompetence. MMWR 42(RR-4):1, 1993.

29. Centers for Disease Control and Prevention: Health information for internation travel, 1996-1997. Atlanta, Department of Health and Human Services, 1997.

30. Chabala S, Williams M, Amenta R, et al: Confirmed rabies exposure during pregnancy: Treatment with human rabies immune globulin and human diploid cell vaccine. Am J Med 91:423, 1991.

31. Chutivongse S, Wilde H, Benjavongkulchai M, et al: Postexposure rabies vaccination during pregnancy: Effect on 202 women and their infants. Clin Infect Dis 20:818, 1995.

32. Ledwith M, Baltimore RS: Management of rabies exposures in pediatric practice. Curr Opin Pediatr 9:478, 1997.

33. Smith JS, Fishbein DB, Rupprecht CE, et al: Unexplained rabies in three immigrants in the United States. N Engl J Med 324:205, 1991.

Peripheral Neuropathy Natural Treatment Options

Peripheral Neuropathy Natural Treatment Options

This guide will help millions of people understand this condition so that they can take control of their lives and make informed decisions. The ebook covers information on a vast number of different types of neuropathy. In addition, it will be a useful resource for their families, caregivers, and health care providers.

Get My Free Ebook


Post a comment